Antidepressant response and subthreshold bipolarity in "unipolar" major depressive disorder: Implications for practice and drug research

Journal of Clinical Psychopharmacology

Volumn 33, Issue 4, 2013, Pages 449-452

  Rihmer, Zoltan ^a   Dome, Peter ^a   Gonda, Xenia ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; PAROXETINE; QUETIAPINE; VALPROIC ACID;

BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DSM-III; DSM-IV; HUMAN; HYPOMANIA CHECKLIST 32; MAJOR DEPRESSION; MENTAL INSTABILITY; META ANALYSIS (TOPIC); MOOD DISORDER QUESTIONNAIRE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUICIDAL IDEATION; SUICIDE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESISTANCE; HUMANS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 84879837823     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318299d2d5     Document Type: Review

References (42)

1. Pacchiarotti I, Valenti M, Bonnin CM, et al. Factors associated with initial treatment response with antidepressants in bipolar disorder. Eur Neuropsychopharmacol. 2011;21:362-369.
2. Ghaemi SN, Ostacher MM, El-Mallakh RS, et al. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010;71:372-380.
3. Rihmer Z, Gonda X. Antidepressant-resistant depression and antidepressant-associated suicidal behaviour: the role of underlying bipolarity. Depress Res Treat. 2011;2011:906462.
4. Amit BH, Weizman A. Antidepressant treatment for acute bipolar depression: an update. Depress Res Treat. 2012;2012:684725.
5. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol Bull. 1987;23:68-73.
6. Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? J Affect Disord. 2005;84:251-257.
7. Rybakowski JK, Suwalska A, Lojko D, et al. Types of depression more frequent in bipolar than in unipolar affective illness: results of the Polish DEP-BI study. Psychopathology. 2007;40:153-158.
8. Woo YS, Chae J-H, Jun T-Y, et al. The bipolar diathesis of treatment-resistant major depressive disorder. Int J Psychiatr Clin Pract. 2008;12:142-146.
9. O'Donovan C, Garnham JS, Hajek T, et al. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk. J Affect Disord. 2008;107:293-298.
10. Li CT, Bai YM, Huang YL, et al. Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Br J Psychiatry. 2012;200:45-51.
11. Dudek D, Rybakowski JK, Siwek M, et al. Risk factors of treatment resistance in major depression: association with bipolarity. J Affect Disord. 2010;126:268-271.
12. Dudek D, Siwek M, Zielinska D, et al. Diagnostic conversions from major depressive disorder into bipolar disorder in an outpatient setting: results of a retrospective chart review. J Affect Disord. 2013;144:112-115.
13. Correa R, Akiskal H, Gilmer W, et al. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord. 2010;127:10-18.
14. Maalouf FT, Porta G, Vitiello B, et al. Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study. J Affect Disord. 2012;138:86-95.
15. Vazquez GH, Tondo L, Undurraga J, et al. Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol. 2013;22:1-13.
16. Vazquez G, Tondo L, Baldessarini RJ. Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review. Pharmacopsychiatry. 2011;44:21-26.
17. Pilhatsch M, Wolf R, Winter C, et al. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study. J Affect Disord. 2010;126:453-457.
18. Tondo L, Baldessarini RJ, Vázquez G, et al. Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatrica Scandinavica. 2013;127:355-364.
19. Akiskal HS, Benazzi F, Perugi G, et al. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord. 2005;85:245-258.
20. Maj M, Pirozzi R, Magliano L, et al. Agitated "unipolar" major depression: prevalence, phenomenology, and outcome. J Clin Psychiatry. 2006;67:712-719.
21. Perlis RH, Uher R, Ostacher M, et al. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Arch Gen Psychiatry. 2011;68:351-360.
22. Rihmer Z, Akiskal H. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord. 2006;94:3-13.
23. Pacchiarotti I, Valenti M, Colom F, et al. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug. J Affect Disord. 2011;129:321-326.
24. Perlis RH, Uher R, Perroud N, et al. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? J Clin Psychiatry. 2012;73:1439-1442.
25. Zimmermann P, Bruckl T, Nocon A, et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry. 2009;66:1341-1352.
26. Angst J, Azorin JM, Bowden CL, et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry. 2011;68:791-798.
27. Angst J, Cui L, Swendsen J, et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry. 2010;167:1194-1201.
28. Fiedorowicz JG, Endicott J, Leon AC, et al. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry. 2011;168:40-48.
29. Azorin JM, Kaladjian A, Adida M, et al. Self-assessment and characteristics of mixed depression in the French national EPIDEP study. J Affect Disord. 2012;143:109-117.
30. Cassano GB, Rucci P, Frank E, et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004;161:1264-1269.
31. Benazzi F, Akiskal HS. Clinical and factor-analytic validation of depressive mixed states: a report from the Ravenna-San Diego collaboration. Curr Opin Psychiatry. 2003;16:71-78.
32. Judd LL, Schettler PJ, Akiskal H, et al. Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes. J Affect Disord. 2012;138:440-448.
33. Bauer MS, Simon GE, Ludman E, et al. 'Bipolarity' in bipolar disorder: distribution of manic and depressive symptoms in a treated population. Br J Psychiatry. 2005;187:87-88.
34. Goldberg JF, Perlis RH, Bowden CL, et al. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009;166:173-181.
35. Thase ME, Macfadden W, Weisler RH, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006;26:600-609.
36. Cutler AJ, Montgomery SA, Feifel D, et al. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. J Clin Psychiatry. 2009;70:526-539.
37. Sugawara H, Sakamoto K, Harada T, et al. Predictors of efficacy in lithium augmentation for treatment-resistant depression. J Affect Disord. 2010;125:165-168.
38. Hantouche EG, Akiskal HS, Lancrenon S, et al. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study. J Affect Disord. 2005;84:243-249.
39. Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002; 287:1840-1847.
40. Nassir Ghaemi S, Miller CJ, Berv DA, et al. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord. 2005;84:273-277.
41. Angst J, Adolfsson R, Benazzi F, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88:217-233.
42. Girardi P, Pompili M, Innamorati M, et al. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods. Hum Psychopharmacol. 2009;24:177-190.